<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33632058</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.</ArticleTitle><Pagination><StartPage>3306</StartPage><EndPage>3322</EndPage><MedlinePgn>3306-3322</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2021.1872189</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two clinically distinct classes of neurodegenerative disorders. Yet, they share a range of genetic, cellular, and molecular features. Hexanucleotide repeat expansions (HREs) in the <i>C9orf72</i> gene and the accumulation of toxic protein aggregates in the nervous systems of the affected individuals are among such common features. Though the mechanisms by which HREs cause toxicity is not clear, the toxic gain of function due to transcribed HRE RNA or dipeptide repeat proteins (DPRs) produced by repeat-associated non-AUG translation together with a reduction in C9orf72 expression are proposed as the contributing factors for disease pathogenesis in ALS and FTD. In addition, several recent studies point toward alterations in protein homeostasis as one of the root causes of the disease pathogenesis. In this review, we discuss the effects of the C9orf72 HRE in the autophagy-lysosome pathway based on various recent findings. We suggest that dysfunction of the autophagy-lysosome pathway synergizes with toxicity from C9orf72 repeat RNA and DPRs to drive disease pathogenesis.<b>Abbreviation:</b> ALP: autophagy-lysosome pathway; ALS: amyotrophic lateral sclerosis; AMPK: AMP-activated protein kinase; ATG: autophagy-related; ASO: antisense oligonucleotide; C9orf72: C9orf72-SMCR8 complex subunit; DENN: differentially expressed in normal and neoplastic cells; DPR: dipeptide repeat protein; EIF2A/eIF2&#x3b1;: eukaryotic translation initiation factor 2A; ER: endoplasmic reticulum; FTD: frontotemporal dementia; GAP: GTPase-activating protein; GEF: guanine nucleotide exchange factor; HRE: hexanucleotide repeat expansion; iPSC: induced pluripotent stem cell; ISR: integrated stress response; M6PR: mannose-6-phosphate receptor, cation dependent; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MN: motor neuron; MTORC1: mechanistic target of rapamycin kinase complex 1; ND: neurodegenerative disorder; RAN: repeat-associated non-ATG; RB1CC1/FIP200: RB1 inducible coiled-coil 1; SLC66A1/PQLC2: solute carrier family 66 member 1; SMCR8: SMCR8-C9orf72 complex subunit; SQSTM1/p62: sequestosome 1; STX17: syntaxin 17; TARDBP/TDP-43: TAR DNA binding protein; TBK1: TANK binding kinase 1; TFEB: transcription factor EB; ULK1: unc-51 like autophagy activating kinase 1; UPS: ubiquitin-proteasome system; WDR41: WD repeat domain 41.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beckers</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2484-6556</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tharkeshwar</LastName><ForeName>Arun Kumar</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0002-5529-9754</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4010-2357</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospitals Leuven, Department of Neurology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071182" MajorTopicYN="N">Autophagosomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="N">Axonal Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074702" MajorTopicYN="N">Proteostasis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">axonal transport</Keyword><Keyword MajorTopicYN="N">c9orf72</Keyword><Keyword MajorTopicYN="N">dipeptide repeat protein (DPR)</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia (FTD)</Keyword><Keyword MajorTopicYN="N">lysosome</Keyword><Keyword MajorTopicYN="N">smcr8</Keyword><Keyword MajorTopicYN="N">wdr41</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33632058</ArticleId><ArticleId IdType="pmc">PMC8632097</ArticleId><ArticleId IdType="doi">10.1080/15548627.2021.1872189</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meyer K, Kaspar BK.. Glia&#x2013;neuron interactions in neurological diseases: testing non-cell autonomy in a dish. Brain Res. 2017;1656:27&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4939136</ArticleId><ArticleId IdType="pubmed">26778174</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Mollereau B.. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci. 2014;15:233&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">24619348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruegsegger C, Saxena S. Proteostasis impairment in ALS. Brain Res. 2016;1648:571&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">27033833</ArticleId></ArticleIdList></Reference><Reference><Citation>David DC. Aging and the aggregating proteome. Front Genet. 2012;3:247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501694</ArticleId><ArticleId IdType="pubmed">23181070</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Cleveland DW. The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 2011;147:498&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220614</ArticleId><ArticleId IdType="pubmed">22036560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, de Assis DR, et al. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain. 2019;142:1176&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzl JK, Lang CM, Haass C, et al. Impaired protein degradation in FTLD and related disorders. Ageing Res Rev. 2016;32:122&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27166223</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y, Park J, Ki Y. Crosstalk between translation and the aggresome &#x2013; autophagy pathway. Autophagy. 2018;14:1079&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103414</ArticleId><ArticleId IdType="pubmed">28837386</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Robberecht W, Van Den Bosch L.. Modelling amyotrophic lateral sclerosis: progress and possibilities. Dis Model Mech. 2017;10:537&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in ALS genetics. Nat Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael A VE, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:351&#x2013;360.</Citation></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;10:1918&#x2013;1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston CA, Stanton BR, Turner MR, et al. Amyotrophic lateral sclerosis in an urban setting: A population based study of inner city London [2]. J Neurol. 2006;253:1642&#x2013;1643.</Citation><ArticleIdList><ArticleId IdType="pubmed">17219036</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study. Lancet Neurol. 2014;13:1108&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V, et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330:153&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Group TW. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, et al. Mechanisms, and therapeutics&#x202f;: where are we now&#x202f;? Front Neurosci. 2019;13:1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;rea F, Polymenidou M. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med Wkly. 2015;145:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">25635517</ArticleId></ArticleIdList></Reference><Reference><Citation>ITS C-G, Dick KM, Patterson K, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016;86:1736&#x2013;1743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854589</ArticleId><ArticleId IdType="pubmed">27037234</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266:2075&#x2013;2086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647117</ArticleId><ArticleId IdType="pubmed">31119452</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Halliday GM, Kril JJ, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon YA, Fratta P, Traynor BJ, et al. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front Neurosci. 2020;14:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza F, Lozupone M, Seripa D, et al. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nat Rev Neurol. 2020;16:213&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">32203398</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A, Sun M, Ling JP, et al. Splicing repression is a major function of TDP-43 in motor neurons. Acta Neuropathol. 2019;5:813&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802294</ArticleId><ArticleId IdType="pubmed">31332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Lim J, Wang Q, et al. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. Autophagy. 2019;8627:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144840</ArticleId><ArticleId IdType="pubmed">31362587</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Grierson AJ, et al. C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases. 2018;9:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5997165</ArticleId><ArticleId IdType="pubmed">27768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R, Fani G, Bigi A, et al. Partial failure of proteostasis systems counteracting tdp-43 aggregates in neurodegenerative diseases. Int J Mol Sci. 2019;20:3685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6695586</ArticleId><ArticleId IdType="pubmed">31357627</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Shaw PJ, et al. Protein Homeostasis in Amyotrophic Lateral Sclerosis: therapeutic Opportunities? Front Mol Neurosci. 2017;10:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5411428</ArticleId><ArticleId IdType="pubmed">28512398</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik BR, Maddison DC, Smith GA, et al. Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain. 2019;12:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884906</ArticleId><ArticleId IdType="pubmed">31783880</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O, Garcia-Redondo A, Rojas-Garcia R, et al. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum Mol Genet. 2014;23:749&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">24057670</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeene L, Van Schoor E, Race V, et al. An ALS case with 38 (G4C2)-repeats in the C9orf72 gene shows TDP-43 and sparse dipeptide repeat protein pathology. Acta Neuropathol. 2019;137:855&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pubmed">30919029</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat Rev Neurosci. 2016;6:383&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng S-M, Arzberger T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2670399</ArticleId><ArticleId IdType="pubmed">18305538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bento CF, Renna M, Ghislat G, et al. Mammalian Autophagy: how Does It Work? Annu Rev Biochem. 2016;85:685&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">26865532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bingol B. Autophagy and lysosomal pathways in nervous system disorders. Mol Cell Neurosci. 2018;91:167&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">29729319</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Purtell K, Lachance V, et al. Autophagy Receptors and Neurodegenerative Diseases. Trends Cell Biol. 2017;27:491&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">28169082</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicencio B, Labrador M, Nassif W. Implications of Selective Autophagy Dysfunction for ALS Pathology. Cells. 2020;9:381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072226</ArticleId><ArticleId IdType="pubmed">32046060</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L, Baehrecke EH, Ballabio A, et al. Molecular definitions of autophagy and related processes. Embo J. 2017;36:1811&#x2013;1836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494474</ArticleId><ArticleId IdType="pubmed">28596378</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumata K, Nishiyama J, Inoue T, et al. Dynein- and activity-dependent retrograde transport of autophagosomes in neuronal axons. Autophagy. 2010;6:378&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150763</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M, Buratti E, Morselli E, et al. Its Impact on Neurodegenerative Diseases: new Roles for TDP-43 and C9orf72. Front Mol Neurosci. 2017;10:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5447761</ArticleId><ArticleId IdType="pubmed">28611593</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekirdag K, Cuervo AM. Chaperone-mediated autophagy and endosomal microautophagy: joint by a chaperone. J Biol Chem. 2018;293:5414&#x2013;5424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5900761</ArticleId><ArticleId IdType="pubmed">29247007</ArticleId></ArticleIdList></Reference><Reference><Citation>Danieli A, Martens S. p62-mediated phase separation at the intersection of the ubiquitin-proteasome system and autophagy. J Cell Sci. 2018;131:jcs214304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610772</ArticleId><ArticleId IdType="pubmed">30287680</ArticleId></ArticleIdList></Reference><Reference><Citation>Teinert J, Behne R, Wimmer M, et al. Novel insights into the clinical and molecular spectrum of congenital disorders of autophagy. J Inherit Metab Dis. 2020;43:51&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">30854657</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Mizushima N. Autophagy and human diseases. Cell Res. 2014;24:69&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3879707</ArticleId><ArticleId IdType="pubmed">24323045</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B, Kroemer G. Autophagy in the Pathogenesis of Disease. Cell. 2008;132:27&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2696814</ArticleId><ArticleId IdType="pubmed">18191218</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherra SJ, Chu CT, Chu CT. Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol. 2008;3:309&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2544613</ArticleId><ArticleId IdType="pubmed">18806889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2011;70:349&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">21487309</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, Gendron TF, Baker MC, et al. Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72. Acta Neuropathol. 2015;130:863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655160</ArticleId><ArticleId IdType="pubmed">26437865</ArticleId></ArticleIdList></Reference><Reference><Citation>Mis MSC, Brajkovic S, Tafuri F, et al. Development of therapeutics for c9orf72 als/ftd-related disorders. Mol Neurobiol. 2017;54:4466&#x2013;4476.</Citation><ArticleIdList><ArticleId IdType="pubmed">27349438</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;5:615&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Mossevelde S, Van Der Zee J, et al. The c9orf72 repeat size correlates with onset age of disease, dna methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2016;21:1112&#x2013;1124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4960451</ArticleId><ArticleId IdType="pubmed">26481318</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, B&#xe4;umer D, East S, et al. Reduced c9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the c9orf72 hexanucleotide repeat expansion. Neurobiol Aging. 2014;35(1779):e5&#x2013;1779.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang P-W, Pham JT, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Bauer PO, Prudencio M, et al. Reduced c9orf72 gene expression in c9ftd/als is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, Gascon E, Tran H, et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013;126:385&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Bauer CS, et al. The c9orf72 protein interacts with rab1a and the ulk1 complex to regulate initiation of autophagy. Embo J. 2016;35:1656&#x2013;1676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L, Young FL, Boeynaems S, et al. C9orf72 -derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. bioRvix. 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="pubmed">33837088</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, Russ J, Wu K, et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol. 2014;128:525&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4161616</ArticleId><ArticleId IdType="pubmed">24806409</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, Zinman L, Moreno D, et al. Hypermethylation of the cpg island near the g4c2 repeat in als with a c9orf72 expansion. Am J Hum Genet. 2013;92:981&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675239</ArticleId><ArticleId IdType="pubmed">23731538</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj BT, Livesey MR, Zhao C, et al. C9orf72 repeat expansion causes vulnerability of motor neurons to ca2+-permeable ampa receptor-mediated excitotoxicity. Nat Commun. 2018;9:347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Laflamme C, McKeever P, Kumar R, et al. Implementation of an antibody validation procedure: application to the major ALS/FTD disease gene C9ORF72. Elife. 2019;8:e48363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794092</ArticleId><ArticleId IdType="pubmed">31612854</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, MacNair L, McGoldrick P, et al. Isoform-specific antibodies reveal distinct subcellular localizations of c9orf72 in amyotrophic lateral sclerosis. Ann Neurol. 2015;78:568&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">26174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J, Roczniak-Ferguson A, Ferguson SM. C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol Biol Cell. 2016;27:3040&#x2013;3051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5063613</ArticleId><ArticleId IdType="pubmed">27559131</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine TP, Daniels RD, Gatta AT, et al. The product of c9orf72, a gene strongly implicated in neurodegeneration, is structurally related to denn rab-gefs. Bioinformatics. 2013;29:499&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3570213</ArticleId><ArticleId IdType="pubmed">23329412</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S, Subramanian V, Acharya KR. C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor. PeerJ. 2018;6:e5815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6195791</ArticleId><ArticleId IdType="pubmed">30356970</ArticleId></ArticleIdList></Reference><Reference><Citation>Rab SH. GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10:513&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">19603039</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Sheng J, Xu L, et al. Cryo-em structure of c9orf72&#x2013;smcr8&#x2013;wdr41 reveals the role as a gap for rab8a and rab11a. Proc Natl Acad Sci. 2020;20:9876&#x2013;9883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211967</ArticleId><ArticleId IdType="pubmed">32303654</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P, Sellier C, Mackenzie IRA, et al. Novel antibodies reveal presynaptic localization of c9orf72 protein and reduced protein levels in c9orf72 mutation carriers. Acta Neuropathol Commun. 2018;6:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Sundaramoorthy V, Sultana JM, et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet. 2014;23:3579&#x2013;3595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C, Campanari M, Julie Corbier C, et al. Loss of c9orf72 impairs autophagy and synergizes with polyq ataxin&#x2010;2 to induce motor neuron dysfunction and cell death. Embo J. 2016;35:1276&#x2013;1297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Liang C, Swaminathan K, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2016;2:e160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y, Manzano R, Lee Y, et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2017;140:887&#x2013;897.</Citation><ArticleIdList><ArticleId IdType="pubmed">28334866</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Wang H, Tao Z, et al. 72 associates with inactive rag gtpases and regulates mtorc1-mediated autophagosomal and lysosomal biogenesis. Aging Cell. 2020;19:e13126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7189992</ArticleId><ArticleId IdType="pubmed">32100453</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, McKeever PM, Lau A, et al. Synaptic localization of c9orf72 regulates post-synaptic glutamate receptor 1 levels. Acta Neuropathol Commun. 2019;7:161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6813971</ArticleId><ArticleId IdType="pubmed">31651360</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J, Tharkeshwar AK, Amaya C, et al. Wdr41 supports lysosomal response to changes in amino acid availability. Mol Biol Cell. 2018;29(mbc):E17&#x2013;12&#x2013;0703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6249801</ArticleId><ArticleId IdType="pubmed">29995611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadasan R, Hornburg D, Drepper C, et al. C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nat Neurosci. 2016;19:1610&#x2013;1618.</Citation><ArticleIdList><ArticleId IdType="pubmed">27723745</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M-Y, Zoncu R, Hurley J. Structure of the c9orf72 arf gap complex that is haploinsufficient in als and ftd. Nature. 2020;585:251&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8054479</ArticleId><ArticleId IdType="pubmed">32848248</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T, Lin S, Zhuang H, et al. Recent progress in the role of autophagy in neurological diseases. Cell Stress. 2019;3:141&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551859</ArticleId><ArticleId IdType="pubmed">31225510</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015;16:345&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">25991442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625205</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14:207&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5902171</ArticleId><ArticleId IdType="pubmed">28933638</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang -C-C, Wang C, Peng X, et al. Neural-specific deletion of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon degeneration. J Biol Chem. 2010;285:3499&#x2013;3509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823459</ArticleId><ArticleId IdType="pubmed">19940130</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats KA, Seah C, Sahimi A, et al. Small molecule inhibition of PIKFYVE kinase rescues gain- and loss-of-function C9ORF72 ALS/FTD disease processes in vivo. bioRxiv. 2019;685800.</Citation></Reference><Reference><Citation>Shi Y, B V Z, Ichida JK. Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons. JCI Insight. 2019;4(15):e127736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693831</ArticleId><ArticleId IdType="pubmed">31310593</ArticleId></ArticleIdList></Reference><Reference><Citation>Leskel&#xe4; S, Huber N, Rostalski H, et al. C9orf72 proteins regulate autophagy and undergo autophagosomal or proteasomal degradation in a cell type-dependent manner. Cells. 2019;8:1233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6829620</ArticleId><ArticleId IdType="pubmed">31658762</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PM, Zhou X, Robins AM, et al. The als/ftld associated protein c9orf72 associates with smcr8 and wdr41 to regulate the autophagy-lysosome pathway. Acta Neuropathol Commun. 2016;4:51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali CP, Patino M, Tai YK, et al. C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy. Acta Neuropathol. 2019;138(5):795&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802287</ArticleId><ArticleId IdType="pubmed">31327044</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, Pfister V, Gaucherot A, et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. Embo J. 2020;39(4):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugolino J, Ji YJ, Conchina K, et al. Loss of c9orf72 enhances autophagic activity via deregulated mtor and tfeb signaling. PLoS Genet. 2016;12:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119725</ArticleId><ArticleId IdType="pubmed">27875531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji YJ, Ugolino J, Brady NR, et al. Systemic deregulation of autophagy upon loss of als- and ftd-linked c9orf72. Autophagy. 2017;13:1254&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5529072</ArticleId><ArticleId IdType="pubmed">28319438</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang BL. C9orf72&#x2019;s interaction with rab gtpases&#x2014;modulation of membrane traffic and autophagy. Front Cell Neurosci. 2016;10:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5053994</ArticleId><ArticleId IdType="pubmed">27774051</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung J, Nayak A, Schaeffer V, et al. Multiplex image-based autophagy rnai screening identifies smcr8 as ulk1 kinase activity and gene expression regulator. Elife. 2017;6:1&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5323046</ArticleId><ArticleId IdType="pubmed">28195531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WY, Tai YK, Chang JC, et al. The als-ftd-linked gene product, c9orf72, regulates neuronal morphogenesis via autophagy. Autophagy. 2019;15:827&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526867</ArticleId><ArticleId IdType="pubmed">30669939</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J, Tharkeshwar AK, Talaia G, et al. PQLC2 signals lysosomal cationic amino acid abundance to the C9orf72 complex. J Cell Biol. 2019;219:670034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7039192</ArticleId><ArticleId IdType="pubmed">31851326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Otomo A, Kunita R, et al. Loss of als2/alsin exacerbates motor dysfunction in a sod1h46r-expressing mouse als model by disturbing endolysosomal trafficking. PLoS One. 2010;5(3):e9805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842444</ArticleId><ArticleId IdType="pubmed">20339559</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Hung S-T, Rocha G, et al. Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons. JCI Insight. 2019;4:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693831</ArticleId><ArticleId IdType="pubmed">31310593</ArticleId></ArticleIdList></Reference><Reference><Citation>Puertollano R, Ferguson SM, Brugarolas J, et al. The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. Embo J. 2018;37:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983138</ArticleId><ArticleId IdType="pubmed">29764979</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S, Wallace KE, Holzbaur ELF. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J Cell Biol. 2012;196:407&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3283992</ArticleId><ArticleId IdType="pubmed">22331844</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S. Mechanisms of neuronal homeostasis: autophagy in the axon. Brain Res. 2016;1649:143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5045311</ArticleId><ArticleId IdType="pubmed">27038755</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavoe AKH, Holzbaur ELF. Axonal autophagy: mini-review for autophagy in the cns. Neurosci Lett. 2019;697:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6136980</ArticleId><ArticleId IdType="pubmed">29548988</ArticleId></ArticleIdList></Reference><Reference><Citation>Farfel-Becker T, Roney JC, Cheng XT, et al. Neuronal soma-derived degradative lysosomes are continuously delivered to distal axons to maintain local degradation capacity. Cell Rep. 2019;28(51&#x2013;64):e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6696943</ArticleId><ArticleId IdType="pubmed">31269450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Zhou B, Lin M, et al. Axonal autophagosomes recruit dynein for retrograde transport through fusion with late endosomes. J Cell Biol. 2015;209:377&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4427784</ArticleId><ArticleId IdType="pubmed">25940348</ArticleId></ArticleIdList></Reference><Reference><Citation>West RJH, Lu Y, Marie B, et al. Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia. J Cell Biol. 2015;208(7):931&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384727</ArticleId><ArticleId IdType="pubmed">25800055</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbier C, C9ORF SC. 72 is a gdp/gtp exchange factor for rab8 and rab39 and regulates autophagy. Small GTPases. 2017;8:181&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5584738</ArticleId><ArticleId IdType="pubmed">27494456</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q, Wang H, Hao Z, et al. Tdp-43 loss of function increases tfeb activity and blocks autophagosome-lysosome fusion. Embo J. 2016;35:121&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718457</ArticleId><ArticleId IdType="pubmed">26702100</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Suzuki N, Wang J, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. 2016;8(347):347ra93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mccauley ME, Rourke JGO, Y&#xe1;&#xf1;ez A, et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585(7823):96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Majcher V, Goode A, James V, et al. Autophagy receptor defects and ALS-FTLD. Mol Cell Neurosci. 2015;66:43&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">25683489</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo JM, Ordureau A, Paulo JA, et al. The pink1-parkin mitochondrial ubiquitylation pathway drives a program of optn/ndp52 recruitment and tbk1 activation to promote mitophagy. Mol Cell. 2015;60:7&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4592482</ArticleId><ArticleId IdType="pubmed">26365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18:631&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen WC, Li HY, Chen GC, et al. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy- mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy. 2015;11:685&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4502753</ArticleId><ArticleId IdType="pubmed">25484089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Gu Y, Abudu YP, et al. Phosphorylation of syntaxin 17 by tbk1 controls autophagy initiation. Dev Cell. 2019;49(130&#x2013;144):e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6907693</ArticleId><ArticleId IdType="pubmed">30827897</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumbarello DA, Waxse BJ, Arden SD, et al. Autophagy receptors link myosin vi to autophagosomes to mediate tom1-dependent autophagosome maturation and fusion with the lysosome. Nat Cell Biol. 2012;14:1024&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472162</ArticleId><ArticleId IdType="pubmed">23023224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao X, Zou L, Wu Y. Regulation of autophagy by the rab gtpase network. Cell Death Differ. 2014;21:348&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3921601</ArticleId><ArticleId IdType="pubmed">24440914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyttinen JMT, Niittykoski M, Salminen A, et al. Maturation of autophagosomes and endosomes: a key role for rab7. Biochim Biophys Acta Mol Cell Res. 2013;1833:503&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">23220125</ArticleId></ArticleIdList></Reference><Reference><Citation>Campa CC, Rab HE. 11 and phosphoinositides&#x202f;: A synergy of signal transducers in the control of vesicular traf fi cking. Adv Biol Regul. 2017;63:132&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27658318</ArticleId></ArticleIdList></Reference><Reference><Citation>E-N N, Debnath J, Brown EJ. Ubiquilins accelerate autophagosome maturation and promote cell survival during nutrient starvation. Autophagy. 2009;5:573&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R, Bett JS, Keuss MJ, et al. Ubqln2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell. 2016;166:935&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ent&#xfc;rk M, Lin G, Zuo Z, et al. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat Cell Biol. 2019;21(3):384&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka M, Ito D, Yagi T, et al. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis. Hum Mol Genet. 2015;24:1617&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pubmed">25398946</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallings RL, Humble SW, Ward ME, et al. Dysfunction at the centre of parkinson&#x2019;s disease and frontotemporal dementia/amyotrophic lateral sclerosis. Trends Neurosci. 2019;42:899&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6931156</ArticleId><ArticleId IdType="pubmed">31704179</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;der B, Wrocklage C, Pan C, et al. Integral and associated lysosomal membrane proteins. Traffic. 2007;8:1676&#x2013;1686.</Citation><ArticleIdList><ArticleId IdType="pubmed">17897319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji YJ, Ugolino J, Zhang T, et al. 72/alfa-1 controls tfeb/hlh-30-dependent metabolism through dynamic regulation of rag gtpases. PLOS Genet. 2020;16:e1008738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188304</ArticleId><ArticleId IdType="pubmed">32282804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan Y, Sullivan PM, Hu F. SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis. Autophagy. 2019;15:871&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526807</ArticleId><ArticleId IdType="pubmed">30696333</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang T, Ji YJ, et al. A c9orf72&#x2013;carm1 axis regulates lipid metabolism under glucose starvation-induced nutrient stress. Genes Dev. 2018;32:1380&#x2013;1397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217731</ArticleId><ArticleId IdType="pubmed">30366907</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q, Yang M, Liang C, et al. c9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy. 2019;16(9):1635&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386604</ArticleId><ArticleId IdType="pubmed">31847700</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, C9orf WJ.72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism. Autophagy. 2019;15:913&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526819</ArticleId><ArticleId IdType="pubmed">30767689</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K, Pasterkamp RJ. Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 2019;137(6):859&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. 2009;10:623&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">19672277</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada SB, Gendron TF, Niccoli T, et al. Rps25 is required for efficient ran translation of c9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nat Neurosci. 2019;22(9):1383&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713615</ArticleId><ArticleId IdType="pubmed">31358992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, Bieniek KF, Gendron TF, et al. Unconventional translation of c9orf72 ggggcc expansion generates insoluble polypeptides specific to c9ftd/als. Neuron. 2013;77:639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, Haney MS, Morgens DW, et al. Crispr-cas9 screens in human cells and primary neurons identify modifiers of c9orf72 dipeptide-repeat-protein toxicity. Nat Genet. 2018;50:603&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893388</ArticleId><ArticleId IdType="pubmed">29507424</ArticleId></ArticleIdList></Reference><Reference><Citation>LaClair KD, Zhou Q, Michaelsen M, et al. Congenic expression of poly-ga but not poly-pr in mice triggers selective neuron loss and interferon responses found in c9orf72 als. Acta Neuropathol. 2020;140(2):121&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360660</ArticleId><ArticleId IdType="pubmed">32562018</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Crippa V, Vezzoli G, et al. The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases. Cell Stress Chaperones. 2018;23:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran-Heravi Y, Van Broeckhoven C. van der Zee J. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol Dis. 2020;134:104639.</Citation><ArticleIdList><ArticleId IdType="pubmed">31626953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20:649&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan JR, Kolaitis RM, Taylor JP, et al. Eukaryotic stress granules are cleared by autophagy and cdc48/vcp function. Cell. 2013;153:1461&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760148</ArticleId><ArticleId IdType="pubmed">23791177</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Kovacs D, et al. Phase separation of c9orf72 dipeptide repeats perturbs stress granule dynamics. Mol Cell. 2017;65(1044&#x2013;1055):e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, McAvoy K, Russell K, et al. Repeat&#x2010;associated non&#x2010; aug translation in c9orf72&#x2010; als/ftd is driven by neuronal excitation and stress. EMBO Mol Med. 2019;11:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6365928</ArticleId><ArticleId IdType="pubmed">30617154</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, Wang S, Mestre AA, et al. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2&#x3b1; phosphorylation. Nat Commun. 2018;9(1):51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Hornburg D, Czuppa M, et al. C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci Alliance. 2018;1:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharjan N, K&#xfc;nzli C, Buthey K, et al. 72 regulates stress granule formation and its deficiency impairs stress granule assembly, hypersensitizing cells to stress. Mol Neurobiol. 2017;54:3062&#x2013;3077.</Citation><ArticleIdList><ArticleId IdType="pubmed">27037575</ArticleId></ArticleIdList></Reference><Reference><Citation>Fay MM, Anderson PJ, Ivanov P. Als/ftd-associated c9orf72 repeat rna promotes phase transitions in vitro and in cells. Cell Rep. 2017;21:3573&#x2013;3584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5741101</ArticleId><ArticleId IdType="pubmed">29262335</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Vance C, Nishimura AL, et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci. 2014;127:1263&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Serio A, Arjun A, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol. 2014;10:677&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I-F, Guo B-S, Liu Y-C, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A. 2012;109:15024&#x2013;15029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying Z, Xia Q, Hao Z, et al. TARDBP/TDP-43 regulates autophagy in both MTORC1-dependent and MTORC1-independent manners. Autophagy. 2016;12:707&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4836031</ArticleId><ArticleId IdType="pubmed">27050460</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C, Deisel J, Aufschnaiter A, et al. 43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity. Hum Mol Genet. 2018;27:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">29474575</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Bento-Abreu A, Gendron TF, et al. A zebrafish model for c9orf72 als reveals rna toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabe Y, Mori K, Yamashita T, et al. Rna exosome complex degrades expanded hexanucleotide repeat rna in c9orf72 ftld/als. Embo J. 2020;39(19):e102700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7527818</ArticleId><ArticleId IdType="pubmed">32830871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K, Yagi T, Cammack AJ, et al. Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum Mol Genet. 2016;25:1803&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Lehmer C, Mart&#x131; A, et al. In situ structure of neuronal c9orf72 poly-ga aggregates reveals proteasome recruitment article in situ structure of neuronal c9orf72 poly-ga aggregates reveals proteasome recruitment. Cell. 2018;172(4):696&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-gonzalez R, Lu Y, Gendron TF, et al. Mitochondrial function and increases oxidative stress and dna damage in ipsc-derived motor neurons poly (gr) in c9orf72 -related als/ftd compromises mitochondrial function and increases oxidative stress and dna damage in ipsc-derived motor neurons. Neuron. 2016;92:383&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S, Twelvetrees AE, Moughamian AJ, et al. Axonal Transport: cargo-Specific Mechanisms of Motility and Regulation. Neuron. 2014;84:292&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4269290</ArticleId><ArticleId IdType="pubmed">25374356</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Stoklund Dittlau K. Van Den Bosch L. Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications. Semin Cell Dev Biol. 2019;99:133&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">31542222</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Julien JP. Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci. 2013;14:161&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">23361386</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Naujock M, Fumagalli L, et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun. 2017;8:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N, Pal A, Lojewski X, et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol Dis. 2018;115:167&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, Sahai E, Kelly G, et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci. 2010;107:20523&#x2013;20528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C, Shao Q, Zhang W, et al. Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models. Hum Mol Genet. 2019;28:3940&#x2013;3953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282195</ArticleId><ArticleId IdType="pubmed">31625563</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Crippa V, Rusmini P, et al. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy. 2017;13:1280&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5584856</ArticleId><ArticleId IdType="pubmed">28402699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Taylor JP. Lost in Transportation: nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases. Neuron. 2017;96:285&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x10d; A, Mertens J, Boeynaems S, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015;18:1226&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Grima JC, et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat Neurosci. 2016;19:668&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Daigle JG, Cunningham KM, et al. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell. 2018;173(958&#x2013;971):e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestrini MJ, Johnson JR, Kumar AV, et al. Nuclear Export Inhibition Enhances HLH-30/TFEB Activity, Autophagy, and Lifespan. Cell Rep. 2018;23:1915&#x2013;1921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991088</ArticleId><ArticleId IdType="pubmed">29768192</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott CJ. Clinical trials in amyotrophic lateral sclerosis. Curr Opin Neurol. 2019;32:758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">31335338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B, Kroemer G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell. 2019;176:11&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347410</ArticleId><ArticleId IdType="pubmed">30633901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsui S, Otomo A, Nozaki M, et al. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model. Mol Brain. 2018;11:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5975400</ArticleId><ArticleId IdType="pubmed">29843805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, Pandey UB. Autophagy Dysregulation in ALS: when Protein Aggregates Get Out of Hand. Front Mol Neurosci. 2017;10:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Rusmini P, Galbiati M, et al. The Regulation of the Small Heat Shock Protein B8 in Misfolding Protein Diseases Causing Motoneuronal and Muscle Cell Death. Front Neurosci. 2019;13:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6688727</ArticleId><ArticleId IdType="pubmed">31427919</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine TD, Miller RG, Bradley WG, et al. Phase I clinical trial of safety of L-serine for ALS patients. Amyotroph Lateral Scler Front Degener. 2017;18:107&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">27589995</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunlop RA, Carney JM. Mechanisms of L -Serine-Mediated Neuroprotection Include Selective Activation of Lysosomal Cathepsins B and L. Neurotox Res. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32242285</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J, Zhou F, Xiong X, et al. Enhancing the retrograde axonal transport by curcumin promotes autophagic flux in N2a/APP695swe cells. Aging (Albany NY). 2019;11:7036&#x2013;7050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6756876</ArticleId><ArticleId IdType="pubmed">31488728</ArticleId></ArticleIdList></Reference><Reference><Citation>Beel S, Herdewyn S, Fazal R, et al. Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice 11 Medical and Health Sciences 1109 Neurosciences. Mol Neurodegener. 2018;13:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192075</ArticleId><ArticleId IdType="pubmed">30326935</ArticleId></ArticleIdList></Reference><Reference><Citation>Beel S, Moisse M, Damme M, et al. Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo. Hum Mol Genet. 2017;26:2850&#x2013;2863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886064</ArticleId><ArticleId IdType="pubmed">28453791</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Van Hoecke A, Lambrechts D, et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol. 2008;181:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2287280</ArticleId><ArticleId IdType="pubmed">18378771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao AW, McKay A, Singh PP, et al. Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci. 2017;18:325&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6040832</ArticleId><ArticleId IdType="pubmed">28435163</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M, Gijselinck I, Van Der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">16862115</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappella M, Ciotti C, Cohen-tannoudji M, et al. Gene therapy for als &#x2014; a perspective. Int J Mol Sci. 2019;20(18)4388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771059</ArticleId><ArticleId IdType="pubmed">31500113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, et al. Targeted degradation of sense and antisense c9orf72 rna foci as therapy for als and frontotemporal degeneration. Proc Natl Acad Sci U S A. 2013;110(47):4530&#x2013;4539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Riboldi G, Zanetta C, Ranieri M, et al. Antisense oligonucleotide therapy for the treatment of c9orf72 als/ftd diseases. Mol Neurobiol. 2014;50:721&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">24809691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, et al. Gain of toxicity from als/ftd-linked repeat expansions in c9orf72 is alleviated by antisense oligonucleotides targeting ggggcc-containing rnas. Neuron. 2016;90:535&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Cabrera GT, Tran H, et al. Human c9orf72 hexanucleotide expansion reproduces rna foci and dipeptide repeat proteins but not neurodegeneration in bac transgenic mice. Neuron. 2015;88:902&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R, Liefhebber JM, Garc&#xed;a-Osta A, et al. Targeting rna-mediated toxicity in c9orf72 als and/or ftd by rnai-based gene therapy. Mol Ther Nucleic Acids. 2019;16:26&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393708</ArticleId><ArticleId IdType="pubmed">30825670</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Bonini NM. Progress in neurobiology repeat-associated non-aug (ran) translation mechanisms are running into focus for ggggcc-repeat associated als/ftd. Prog Neurobiol. 2019;183:101697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6941355</ArticleId><ArticleId IdType="pubmed">31550516</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KM, Glineburg MR, Kearse MG, et al. Ran translation at c9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat Commun. 2017;8(1):2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y, Ghadge G, Masaki K, et al. Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol Dis. 2018;116:155&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6331062</ArticleId><ArticleId IdType="pubmed">29792928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Mareljic N, Michaelsen M, et al. Active poly-ga vaccination prevents microglia activation and motor deficits in a c9orf72 mouse model. EMBO Mol Med. 2019;12(2):e10919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005532</ArticleId><ArticleId IdType="pubmed">31858749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>